Dysregulation of mTORC2 has been linked to several diseases, including cancer, diabetes, and neurodegenerative disorders. In cancer, mTORC2 can promote tumor growth and survival by activating Akt and other oncogenic pathways. Similarly, in diabetes, mTORC2 contributes to insulin resistance by affecting glucose metabolism. Understanding the role of mTORC2 in these diseases can provide insights into potential therapeutic targets.
